Lv2
152 积分 2022-08-19 加入
Textbook of Cell Signalling in Cancer An Educational Approach
7小时前
已关闭
The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types
1天前
已关闭
Hallmarks of artificial intelligence contributions to precision oncology
1天前
已完结
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
14天前
已完结
Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non–Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA
19天前
已完结
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials
20天前
已关闭
HRS-5965, a small-molecule factor B inhibitor, in healthy participants and participants with renal insufficiency: A first-in-human, phase 1 trial
1个月前
已完结
Safety, tolerability, pharmacokinetics, and pharmacodynamics of SHR-2010, a novel anti-MASP-2 antibody, in healthy volunteers: a randomized, double-blind, placebo-controlled phase 1 study
1个月前
已完结
Adjusting Survival Time Estimates to Account for Treatment Switching in Randomized Controlled Trials—an Economic Evaluation Context
1个月前
已关闭
Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trial
1个月前
已完结
皖公网安备34019202002308
